Funding for this research was provided by:
the National Natural Science Foundation of China (31672496, 31802142, 81872071, 81672502)
the National Key Research and Development Program of China (2016YFC1302204, 2017YFC1308601)
Chongqing Natural Science foundation of Chongqing (cstc2019jcyj-zdxmX0033)
Chongqing University Innovation Team Building Program funded projects (CXTDX201601010)
the Fundamental Research Funds for the Central Universities (XDJK2019C089)
the China Postdoctoral Science Foundation (2019T120801, 2017M620408)
Received: 3 December 2020
Accepted: 16 March 2021
First Online: 10 April 2021
: All animal experiments were approved by the Experimental Animal Care and Use Committees of the Institute of Sericulture and Systems Biology and Institutional Animal Care and Use Committees of the Southwest University (Chongqing, China). And all the PDX model tumors were get from the Ninth People’s Hospital of Chongqing. The privacy of patients has been protected carefully and the experiment of PDX model were carried out with the consent of the patient’s family.
: The corresponding author and all the co-authors have agreed to the publication of the manuscript to Journal of Experimental and Clinical Cancer Research as a research article and declare that they have no conflict of interest as to the results presented.
: The authors declare that they have no competing interests.